News From Europe!: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on News From Europe!.

Press releases published on June 9, 2026

Jun. 9, 2026

Matisse Pharmaceuticals receives FDA Fast Track Designation for isupartob sodium in sepsis

Indeterminate GlobeNewswire

Jun. 9, 2026

Linnaeus Therapeutics Announces Selection of LNS8801 into the National Institute on Aging Interventions Testing Program

Indeterminate GlobeNewswire

Jun. 9, 2026

BulkQuant Expands AI-Assisted Trading Platform for Crypto, Forex, and Stock Market Automation in 2026

Indeterminate GlobeNewswire

Jun. 9, 2026

Nasus Pharma Announces Positive Results from Preclinical Pharmacokinetic and Safety Study of Intranasal Ondansetron (NS003) 

Indeterminate GlobeNewswire

Jun. 9, 2026

Windward Bio Doses First Patients in Phase 2 SIRIUS COPD Study of Ultra Long-Acting Anti-TSLP Antibody WIN378

Indeterminate GlobeNewswire

Jun. 9, 2026

Vaxart to Participate in BTIG Infectious Disease Day 2026

Indeterminate GlobeNewswire

Jun. 9, 2026

GoldHaven Closes Upsized C$5.75 Million LIFE Financing to Advance Magno and Copeçal Projects

Indeterminate GlobeNewswire

Jun. 9, 2026

VEON Appoints Serkan Ozturk as Chief of Staff & Strategy Officer

Indeterminate GlobeNewswire

Jun. 9, 2026

Actuate Therapeutics’ Elraglusib Selected for Evaluation in BEACON2 Trial for High-Risk Pediatric Neuroblastoma

Indeterminate GlobeNewswire

Jun. 9, 2026

Corvus Pharmaceuticals Announces Additional Investment in Angel Pharmaceuticals to Advance the Development of Soquelitinib in China

Indeterminate GlobeNewswire

Jun. 9, 2026

SCHMID Group announces Agreement for New China Manufacturing Campus to Support Future Growth

Indeterminate GlobeNewswire

Jun. 9, 2026

Ballou named among Europe's best PR agencies while expanding U.S. client portfolio

Indeterminate GlobeNewswire

Jun. 9, 2026

Invivyd Announces First Participants Dosed in LIBERTY, a Phase 3 Clinical Trial to Evaluate the Safety and Tolerability of VYD2311 Antibody Versus mRNA COVID Vaccine and to Characterize the Safety and Immunology of Antibody and mRNA Vaccine…

Indeterminate GlobeNewswire

Jun. 9, 2026

Holm Security expands platform with Active Directory Security to harden the most-targeted layer of business identity

Indeterminate GlobeNewswire

Jun. 9, 2026

Holm Security erweitert seine Plattform mit Active Directory Security, um die am häufigsten angegriffene Ebene der Unternehmensidentität besser zu schützen

Indeterminate GlobeNewswire

Jun. 9, 2026

Holm Security enrichit sa plateforme avec Active Directory Security afin de renforcer la couche la plus ciblée de l’identité numérique des entreprises

Indeterminate GlobeNewswire

Jun. 9, 2026

MitoRx Therapeutics Strengthens Leadership Team with C-Suite and Board Appointments to Support Next Phase of Growth

Indeterminate GlobeNewswire

Jun. 9, 2026

DBV Technologies Revises Participation in the Goldman Sachs 47th Annual Global Healthcare Conference

Indeterminate GlobeNewswire

Jun. 9, 2026

DBV Technologies révise sa participation à la 47ème conférence annuelle Global Healthcare organisée par Goldman Sachs

Indeterminate GlobeNewswire

Jun. 9, 2026

Antag Therapeutics Elects Keith Leonard as Chairman of its Board of Directors

Indeterminate GlobeNewswire